NYSE:METMetlife Stock Price, Forecast & News

$38.97

+1.09 (+2.88 %)

(As of 06/4/2020 03:00 PM ET)

Add

Compare

Today's Range

$37.15

Now: $38.97▼

$39.09

50-Day Range

$30.77

MA: $33.87▼

$37.48

52-Week Range

$22.85

Now: $38.97▼

$53.28

Volume3.08 million shs

Average Volume6.39 million shs

Market Capitalization$35.37 billion

P/E Ratio4.15

Dividend Yield5.06%

Beta1.31

MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability, as well as small business owners' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. The company serves individuals, corporations and their employees, and other institutions and their members through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and sponsoring organizations and affinity groups, as well as through career and independent agencies, bancassurance, direct marketing and e-commerce, brokers, and other third-party distribution channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

Beat the Market (BTM) Rank^™

2.3 Analyst's Opinion

Consensus Rating
Metlife has received a consensus rating of Buy. The company's average rating score is 2.56, and is based on 5 buy ratings, 4 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $40.86, Metlife has a potential upside of 5.0% from its current price of $38.91.
Amount of Analyst Coverage
Metlife has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.0 Community Rank

Outperform Votes
Metlife has received 838 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Metlife has received 581 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Metlife has received 59.06% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote “Outperform” if you believe MET will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days.

4.2 Dividend Strength

Dividend Leadership
Metlife is a leading dividend payer. It pays a dividend yield of 5.06%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Metlife has been increasing its dividend for 7 years.
Dividend Coverage
The dividend payout ratio of Metlife is 30.11 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Metlife will have a dividend payout ratio of 30.77 % next year. This indicates that Metlife will be able to sustain or increase its dividend.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Metlife insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.07% of the stock of Metlife is held by insiders.
Percentage Held by Institutions
74.77% of the stock of Metlife is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5 Earnings and Valuation

Earnings Growth
Earnings for Metlife are expected to grow by 10.33% in the coming year, from $5.42 to $5.98 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Metlife is 4.14, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 16.28.
Price to Earnings Ratio vs. Sector
The P/E ratio of Metlife is 4.14, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 19.97.
Price to Book Value per Share Ratio
Metlife has a P/B Ratio of 0.54. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.59 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Life insurance

Sub-IndustryLife & Health Insurance

SectorFinance

Current SymbolNYSE:MET

Previous Symbol

CUSIP59156R10

CIK1099219

Webwww.metlife.com

Phone212-578-9500

Debt

Debt-to-Equity Ratio0.21

Current Ratio0.16

Quick Ratio0.16

Price-To-Earnings

Trailing P/E Ratio4.15

Forward P/E Ratio7.19

P/E GrowthN/A

Sales & Book Value

Annual Sales$69.62 billion

Price / Sales0.51

Cash Flow$6.29 per share

Price / Cash Flow6.20

Book Value$72.18 per share

Price / Book0.54

Profitability

EPS (Most Recent Fiscal Year)$6.11

Net Income$5.90 billion

Net Margins12.37%

Return on Equity8.85%

Return on Assets0.81%

Miscellaneous

Employees49,000

Outstanding Shares907,590,000

Market Cap$35.37 billion

Next Earnings Date7/29/2020 (Estimated)

OptionableOptionable

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

Metlife (NYSE:MET) Frequently Asked Questions

How has Metlife's stock been impacted by COVID-19 (Coronavirus)?

Metlife's stock was trading at $33.30 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MET stock has increased by 16.8% and is now trading at $38.91. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Metlife?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Metlife.

When is Metlife's next earnings date?

Metlife is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Metlife.

How were Metlife's earnings last quarter?

Metlife Inc (NYSE:MET) posted its quarterly earnings results on Wednesday, May, 6th. The financial services provider reported $1.58 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.44 by $0.14. The financial services provider earned $15.54 billion during the quarter, compared to analysts' expectations of $16.38 billion. Metlife had a return on equity of 8.85% and a net margin of 12.37%. The company's revenue for the quarter was up .6% on a year-over-year basis. During the same quarter last year, the firm posted $1.48 earnings per share. View Metlife's earnings history.

How often does Metlife pay dividends? What is the dividend yield for Metlife?

Metlife announced a quarterly dividend on Tuesday, April 28th. Stockholders of record on Friday, May 8th will be paid a dividend of $0.46 per share on Friday, June 12th. This represents a $1.84 dividend on an annualized basis and a yield of 4.73%. The ex-dividend date of this dividend is Thursday, May 7th. This is a boost from Metlife's previous quarterly dividend of $0.44. View Metlife's dividend history.

How will Metlife's stock buyback program work?

Metlife announced that its Board of Directors has authorized a stock repurchase plan on Thursday, November 1st 2018, which authorizes the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to reacquire up to 4.6% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's board of directors believes its shares are undervalued.

What price target have analysts set for MET?

9 analysts have issued 1 year target prices for Metlife's shares. Their forecasts range from $32.00 to $47.00. On average, they anticipate Metlife's share price to reach $40.86 in the next year. This suggests a possible upside of 5.0% from the stock's current price. View analysts' price targets for Metlife.

What are Wall Street analysts saying about Metlife stock?

Here are some recent quotes from research analysts about Metlife stock:

1. According to Zacks Investment Research, "MetLife has been performing well, led by prudent underwriting and expense management. Its efforts to streamline business and focus on core operations are impressive. Acquisitions made by the company will likely diversify its business. Its shares have underperformed its industry in a year’s time. Nevertheless, its disciplined capital deployment via buybacks and dividend payments is impressive. Strong free cash flow generation is another positive. However, its exposure to catastrophe loss remains a concern. Also, the company's net investment income might continue to decline due to lower interest rates, which will likely weigh on investment yields. Nevertheless, MetLife’s operating earnings of $1.58 per share beat the Zacks Consensus Estimate by 8.97% and also improved 6.7% year over year." (5/28/2020)
2. Wells Fargo & Co analysts commented, "We do not expect much movement in the shares after our meetings. Our EPS estimates and price target are unchanged. We continue to have an Outperform rating on the shares." (6/5/2019)

Has Metlife been receiving favorable news coverage?

News stories about MET stock have trended somewhat negative this week, according to InfoTrie. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Metlife earned a coverage optimism score of -1.0 on InfoTrie's scale. They also gave news headlines about the financial services provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the next several days. View the latest news aboutMetlife.

Are investors shorting Metlife?

Metlife saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 18,200,000 shares, an increase of 13.5% from the April 15th total of 16,030,000 shares. Based on an average trading volume of 8,260,000 shares, the days-to-cover ratio is currently 2.2 days. Approximately 2.4% of the company's stock are sold short. View Metlife's Current Options Chain.

Who are some of Metlife's key competitors?

Some companies that are related to Metlife include AFLAC (AFL), Prudential Financial (PRU), Principal Financial Group (PFG), Lincoln National (LNC), Primerica (PRI), Unum Group (UNM), CNO Financial Group (CNO), American Equity Investment Life (AEL), FBL Financial Group (FFG), National Western Life Group (NWLI), Independence (IHC), Citizens (CIA), Health Insurance Innovations (HIIQ) and Kansas City Life Insurance (KCLI). View all competitors.

What other stocks do shareholders of Metlife own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Metlife investors own include AT&T (T), General Electric (GE), Walt Disney (DIS), Verizon Communications (VZ), IBM (IBM), Pfizer (PFE), Exxon Mobil (XOM), Bank of America (BAC), Johnson & Johnson (JNJ) and Intel (INTC).

Who are Metlife's key executives?

Metlife's management team includes the following people:

Mr. Michel A. Khalaf, CEO, Pres & Director (Age 55)
Mr. John Dennis McCallion CPA, Exec. VP & CFO (Age 45)
Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 60)
Ms. Tamara L. Schock C.A., CPA, Exec. VP & Chief Accounting Officer (Age 47)
Mr. John Arthur Hall, Sr. VP & Head of Investor Relations

What is Metlife's stock symbol?

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Who are Metlife's major shareholders?

Metlife's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.17%), State Street Corp (4.06%), Wellington Management Group LLP (3.49%), Franklin Resources Inc. (1.60%), Geode Capital Management LLC (1.27%) and Diamond Hill Capital Management Inc. (1.10%). Company insiders that own Metlife stock include Carlos M Gutierrez, John D Mccallion, Steven A Kandarian and Steven J Goulart. View institutional ownership trends for Metlife.

Which institutional investors are selling Metlife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, BlackRock Inc., Bank of New York Mellon Corp, Clearbridge Investments LLC, Invesco Ltd., Wells Fargo & Company MN, Two Sigma Advisers LP, and State Street Corp. View insider buying and selling activity for Metlife.

Which institutional investors are buying Metlife stock?

MET stock was bought by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Wellington Management Group LLP, Prudential PLC, Edgar Lomax Co. VA, Morgan Stanley, Morgan Stanley, Acadian Asset Management LLC, and Swiss National Bank. View insider buying and selling activity for Metlife.

How do I buy shares of Metlife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Metlife's stock price today?

One share of MET stock can currently be purchased for approximately $38.91.

How big of a company is Metlife?

Metlife has a market capitalization of $35.31 billion and generates $69.62 billion in revenue each year. The financial services provider earns $5.90 billion in net income (profit) each year or $6.11 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

What is Metlife's official website?

The official website for Metlife is www.metlife.com.

How can I contact Metlife?

Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.

This page was last updated on 6/4/2020 by MarketBeat.com Staff